DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Eugeroic
Eugeroic
Modafinil and Modafinil Analogues: Free Radical Mechanism of the Eugeroic and Cognitive Enhancment Effect Clifford Fong
Patterns Of, and Motivations for Illicit Drug Use Among Long Haul
Why Millennials Are Consuming the Best Stimulants at an Accelerating Rate
World of Cognitive Enhancers
Gatekeepers of Addiction?
Wake-Promoting Agents Beyond Modafinil
Фармакология Pharmacology
List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify
Pill Testing at Music Festivals- Reaching Parts That Other
Drug/Substance Trade Name(S)
Cognitive Enhancement Treating Or Cheating?
Nootropics Use in the Workplace: Psychiatric and Ethical Aftermath Towards the New Frontier of Bioengineering
'Smart Drug' Modafinil Does Enhance Cognition
Name Type Daily Dose Range About Huperzine-A Acetylcholinesterase Inhibitor 0.05-0.4Mg Inhibits Acetylcholine Neurotransmitter Breakdown
Measham, F. and Newcombe, R. (2016
Dopamine Receptors and Transporters
Nootropics• What Are Nootropics?
Counterfeit Formulations: Analytical Perspective on Anorectics
Top View
Identifying Individuals Amenable to Drug Recovery Interventions Through Computational Analysis of Addiction Content in Social Media
MAM-E17 Rat Model Impairments on a Novel Continuous Performance Task: Effects of Potential Cognitive Enhancing Drugs
New Psychoactive Substances: the Local Picture a Research Study and Needs Assessment for Blackburn with Darwen Borough Council
Sleep Medicine, Springer 2015 LA SOCIEDAD
2015 Surface Water Data
Inhibition of the Dopamine Monoamine Transporter DAT by Modafinil Like
DRUGS and PREGNANCY: CLINICAL MANAGEMENT with a CYSTIC FIBROSIS FOCUS Micah Ballif (Kathleen Job, Phd) Department of Chemistry
Search Strategies CINAHL Search Strategy
The Effects of Modafinil in People with a Diagnosis of Schizophrenia
ACR-ACNM Practice Parameter for the Performance of Dopamine (Dat
2021 PRINT TEMPLATE-Updated Spring 2021 Instructions
Clinical Best Practices in Addiction Medicine a Guide for RAAM Clinicians
Product Catalog
416759 1 En Bookbackmatter 331..337
Practical Use and Risk of Modafinil, a Novel Waking Drug
APPENDIX #2 Proposed Penalty Changes for Class 2 Substances